Tom Nolan reviews this week’s research It’s common for people with bronchiectasis to be prescribed carbocysteine or ...

Brensocatib was associated with decreased exacerbation rates in patients with non-CF bronchiectasis, even in those with comorbid COPD.

In bronchiectasis, highly symptomatic patients have a greater risk of exacerbations and may benefit from long-term macrolide treatment.

Finger clubbing, a change in nail shape and fingertip swelling, can be an early indicator of lung cancer, though it often appears in later stages. Thi ...

Miami (October 23, 2025) – The Bronchiectasis and NTM Association announced today that two abstracts using Bronchiectasis and NTM Research Registry data were presented at CHEST 2025, held October ...

We’ve all experienced common issues like headaches, vision changes, nausea, stomach pain, and mouth sores. These don’t tend to cause us much worry because they’re usually symptoms of benign issues ...

It's fall, y'all, and you know what that means—temperatures and leaves drop, football season is in full swing, pumpkin spice everything takes over your senses...and COVID-19 is likely to run rampant ...

Autism symptoms in adults often include social communication difficulties, restricted and repetitive behaviors, and sensory sensitivities. Symptoms can vary widely, from food aversions and sleep ...

Mucoactive agents did little to stave off pulmonary exacerbations of non-cystic fibrosis bronchiectasis, the CLEAR trial showed. In the two-by-two factorial trial testing hypertonic saline and ...

(StatePoint) Getting the correct treatment for bronchiectasis, a chronic lung condition affecting 350,000 to 500,000 adults nationwide, is necessary to slow disease progression and help prevent ...

Prior exacerbations and greater symptom severity independently predicted future exacerbations in patients with bronchiectasis. Long-term macrolide proved beneficial not only for patients with frequent ...

Lyme disease is the most common vector-borne illness in the United States, a potentially disabling infection caused by bacteria transmitted through the bite of an infected tick to people and pets.